{"id":71286,"date":"2026-05-24T15:34:10","date_gmt":"2026-05-24T15:34:10","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/71286\/"},"modified":"2026-05-24T15:34:10","modified_gmt":"2026-05-24T15:34:10","slug":"roche-ceo-expects-pharma-portfolio-to-deliver-sales-growth-through-2030","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/71286\/","title":{"rendered":"Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030"},"content":{"rendered":"<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1qg6i2u eku5yup0\"><a data-type=\"company\" href=\"https:\/\/www.wsj.com\/market-data\/quotes\/CH\/XSWX\/ROP\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">Roche<\/a> <a href=\"https:\/\/www.wsj.com\/market-data\/quotes\/CH\/XSWX\/ROP\" class=\"css-1p1beha-ChicletStyle e1vl9ktx2\" rel=\"nofollow noopener\" target=\"_blank\">ROP 2.42%increase; green up pointing triangle<\/a> Holding expects drugs it already has on the market and a trio of medicines due to be launched shortly to deliver sales growth for its pharmaceutical business through the end of the decade, its chief executive said.<\/p>\n<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1qg6i2u eku5yup0\">The Swiss drugmaker\u2019s on-market pharma portfolio, together with its Gazyva drug for lupus, giredestrant for breast cancer and fenebrutinib for multiple sclerosis, should make up for any hit from generic competition until 2030, Roche Chief Executive Thomas Schinecker said at an event with investors in London on Tuesday.<\/p>\n<p class=\"css-16aepit e1jdulti0\">Copyright \u00a92026 Dow Jones &amp; Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"Roche ROP 2.42%increase; green up pointing triangle Holding expects drugs it already has on the market and a&hellip;\n","protected":false},"author":2,"featured_media":71287,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[6277,34156,6274,1126,6273,230,37941,6275,834,16097,4128,25348,6288,1831,37942,4217,228,37943,37939,37940,6263,337,37944,134,994,34155,17723,22370,6278,5074,6279],"class_list":["post-71286","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-ce-industry-news-filter","tag-chrop","tag-content-types","tag-corporate","tag-corporate-industrial-news","tag-earnings","tag-earnings-projections","tag-factiva-filters","tag-financial-performance","tag-gcapi","tag-healthcare","tag-healthcare-life-sciences","tag-industrial-news","tag-life-sciences","tag-linkendrnrealtime-linkedarticle-dnco20260512006425","tag-management","tag-manufacturing","tag-neuroactive","tag-neuroactive-psychotropic-drugs","tag-neurodegenerative-disease-drugs","tag-newsplus","tag-pharmaceuticals","tag-psychotropic-drugs","tag-roche","tag-roche-holding","tag-rop-eb","tag-sales-figures","tag-senior-level-management","tag-synd","tag-thomas-schinecker","tag-wsj-pro-wsj-com"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/71286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=71286"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/71286\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/71287"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=71286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=71286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=71286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}